CorVista System with PH Add-On vs Imbio RV/LV Software
AI Verdict
Choose CorVista System with PH Add-On if…
Choose CorVista System with PH Add-On if you require a rapid, non-invasive, point-of-care diagnostic solution for initial assessment of coronary artery disease and pulmonary hypertension. This system is ideal when you need quick results within minutes and want to avoid radiation, contrast agents, injections, fasting, or exercise for the patient.
View CorVista System with PH Add-On →Choose Imbio RV/LV Software if…
Choose Imbio RV/LV Software if you need automated, precise measurements of right and left ventricular diameters from existing CTPA scans to aid in risk stratification for pulmonary conditions such as pulmonary embolism. This tool is best suited for integrating into your current radiology workflow (PACS) to provide a fully automated analysis and RV/LV ratio reporting without user intervention after scan completion.
View Imbio RV/LV Software →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CorVista System with PH Add-On | Imbio RV/LV Software |
|---|---|---|
| Pricing | Unknown | Subscription-based |
| Deployment | Cloud-based, point-of-care system. | Cloud-based (Imbio Cloud in AWS with Imbio Bridge), on-premise (Imbio Enterprise as a software-only VMware solution), or via partner platforms (e.g., Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CorVista System with PH Add-OnTool A, the CorVista System, offers superior usability by being a non-invasive, point-of-care solution that requires no radiation, contrast agents, injections, fasting, or exercise. This significantly reduces patient burden and simplifies the clinical workflow at the point of care, providing rapid results within minutes. In contrast, Tool B streamlines the interpretation of existing CTPA scans, which are already invasive procedures.
Clinical Value
CorVista System with PH Add-OnTool A provides a non-invasive diagnostic platform for two complex cardiovascular diseases, coronary artery disease (CAD) and pulmonary hypertension (PH), with high negative predictive values for ruling out these conditions. Its FDA Breakthrough Device designation for PH further highlights its potential to significantly improve diagnostic pathways and patient outcomes. Tool B, while valuable, offers automated measurements for risk stratification from existing CTPA scans, serving as an aid rather than a primary diagnostic tool.
Pricing & Value
Imbio RV/LV SoftwareTool B offers more transparency regarding its pricing model, stating it is 'subscription-based' and 'Based on number of analyses, number of installations.' This provides potential customers with a clearer understanding of the cost structure. Tool A, conversely, only states 'contact for pricing,' offering no insight into its model.
Enterprise Readiness
Imbio RV/LV SoftwareTool B demonstrates superior enterprise readiness by offering flexible deployment options including cloud-based, on-premise, and integration with multiple partner platforms (e.g., Nuance, Aidoc, Siemens Syngo.via). Additionally, its explicit 'third-party HIPAA compliant certified by compliancy group' status provides a stronger assurance of compliance compared to Tool A's 'likely' HIPAA compliance.
Innovation
CorVista System with PH Add-OnTool A presents a more innovative approach by offering an FDA-cleared, non-invasive, point-of-care AI diagnostic platform for CAD and PH that eliminates the need for radiation, contrast agents, injections, fasting, or exercise. This represents a significant shift in diagnostic methodology. Its FDA Breakthrough Device designation for the PH Add-On further underscores its innovative potential.
Support & Docs
Imbio RV/LV SoftwareTool B provides clear and comprehensive support information, including 24/7/365 phone and email support, and explicitly states that user manuals and other documentation are available upon request. While Tool A likely offers support, this information is not as transparently or comprehensively detailed on publicly available channels.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CorVista System with PH Add-On | Imbio RV/LV Software |
|---|---|---|
| Name | CorVista System with PH Add-On | Imbio RV/LV Software |
| Company | Analytics for Life | Imbio |
| Description | An FDA-cleared, non-invasive, point-of-care AI diagnostic platform for rapid assessment of coronary artery disease and pulmonary hypertension using machine-learned algorithms. | An AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism. |
| Key Features | Non-invasive cardiovascular diagnostics, point-of-care testing, machine-learned algorithms for analysis, analyzes cardiac and hemodynamic signals, no radiation, contrast agents, injections, fasting, or exercise required, rapid results available within minutes, secure web portal for physician access to analysis, modular design with disease-specific add-ons (CAD, PH). | Automated measurement of right and left ventricular diameters, calculation and reporting of RV/LV ratio, artificial intelligence algorithm for ventricle identification and measurement, provides annotated images showing ventricular measurements, generates summary PDF reports, fully automated workflow, no user intervention required after scan completion, DICOM compliant input and output, integration with standard reading environments (PACS). |
Videos
Demos, reviews, and walkthroughs featuring CorVista System with PH Add-On and Imbio RV/LV Software.